11-TREO: A Phase II Study of Treosulfane/Fiudarabine/Low Dose Total Body Irradiation as a Preparative Regimen for Children with AMLIMDS Undergoing Allogeneic Hematopoietic Cell Transplantation

Grant

Date/time Interval

  • August 23, 2013 - March 23, 2017
  • Total Award Amount

  • 43200.00
  • Direct Costs

  • 33882.00
  • Sponsor Award Id

  • Contributor

  • Chewning III, Joseph   Principal Investigator  
  • Goldman, Frederick   Investigator  
  • Haines, Hilary   Investigator